Commentary
COX-2: Where are we in 2003? - Be strong and resolute: continue to use COX-2 selective inhibitors at recommended dosages in appropriate patients
Arthritis Res Ther 2003, 5:28-31 doi:10.1186/ar617
Accesses
- Last 30 days: 40 accesses
- Last 365 days: 376 accesses
- All time: 3821 accesses
